More articles from Invited Perspective

You have access
Can PET/CT Guide the Personalized Treatment of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms?
Orazio Schillaci

Journal of Nuclear Medicine November 1, 2014, 55 (11) 1757-1758; DOI: https://doi.org/10.2967/jnumed.114.147538
You have access
Is Radiocholine PET/CT Already Clinically Useful in Patients with Prostate Cancer?
Luigi Mansi, Vincenzo Cuccurullo and Laura Evangelista

Journal of Nuclear Medicine September 1, 2014, 55 (9) 1401-1403; DOI: https://doi.org/10.2967/jnumed.114.142679
You have access
A Flexible, Multifaceted Approach Is Needed in Health Technology Assessment of PET
Issa J. Dahabreh and Constantine Gatsonis

Journal of Nuclear Medicine August 1, 2014, 55 (8) 1225-1227; DOI: https://doi.org/10.2967/jnumed.114.142331
You have access
¹⁸F-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis
Ilse J.E. Kouijzer, Chantal P. Bleeker-Rovers and Wim J.G. Oyen

Journal of Nuclear Medicine July 1, 2014, 55 (7) 1045-1046; DOI: https://doi.org/10.2967/jnumed.114.140707
You have access
Diversification of ⁹⁹Mo/^99mTc Supply
David Dick

Journal of Nuclear Medicine June 1, 2014, 55 (6) 875-876; DOI: https://doi.org/10.2967/jnumed.114.138008
You have access
¹⁸F-DOPA and Other Radiopharmaceuticals for Imaging Unknown Primary Neuroendocrine Tumors
Orazio Schillaci

Journal of Nuclear Medicine March 1, 2014, 55 (3) 357-359; DOI: https://doi.org/10.2967/jnumed.113.133116
You have access
A Digital Revolution in Radiosynthesis
David E. Reichert

Journal of Nuclear Medicine February 1, 2014, 55 (2) 181-182; DOI: https://doi.org/10.2967/jnumed.113.132498
You have access
¹⁸F-FDG Imaging of Carotid Arteries for Identifying the Vulnerable Patient: Are We at the Beginning of the End?
Balaji Tamarappoo and Rory Hachamovitch

Journal of Nuclear Medicine December 1, 2013, 54 (12) 2021-2023; DOI: https://doi.org/10.2967/jnumed.113.126607
You have access
¹⁸F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO
Laura M. Kenny

Journal of Nuclear Medicine November 1, 2013, 54 (11) 1855-1856; DOI: https://doi.org/10.2967/jnumed.113.126342
You have access
Standards for Reporting PET Clinical Trials
Janet F. Eary and Kenneth A. Krohn

Journal of Nuclear Medicine September 1, 2013, 54 (9) 1516-1517; DOI: https://doi.org/10.2967/jnumed.113.127845

Main menu

User menu

Search

More articles from Invited Perspective

Pages